Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, February 7, 2023
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
Eliana Merle Initiated (TERN) at Strong Buy and Held Target at $19 on, Feb 7th, 2023
Eliana Merle of UBS, Initiated "Terns Pharmaceuticals, Inc." (TERN) at Strong Buy and Held Target at $19 on, Feb 7th, 2023.
Eliana has made no other calls on TERN in the last 4 months.
There are 2 other peers that have a rating on TERN. Out of the 2 peers that are also analyzing TERN, 1 agrees with Eliana's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Ed Arce of "HC Wainwright & Co." Maintained at Hold with Increased Target to $7 on, Thursday, December 29th, 2022
This is the rating of the analyst that currently disagrees with Eliana
- Corinne Jenkins of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $14 on, Tuesday, December 20th, 2022
